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The Editorial on Research Topic
Non-coding RNA Regulation: Lessons fromModel Organisms and Impact on Human Health
This research topic highlights the great interest and cautious optimism surrounding our constantly
expanding understanding of the roles played by non-coding RNA (ncRNA) molecules in
fundamental biology as well as in human health, aging, and disease.
In this topic, five review articles and one hypothesis/theory paper cover in breadth and depth
the established, emerging, and controversial aspects of ncRNA biology. Claycomb discusses how
we owe, at least in large part, today’s broad interest in this area of biology to the discovery and
characterization of RNA interference in the tiny soil worm Caenorhabditis elegans, a simple and
elegant model organism that continues to be at the forefront of ncRNA research (Youngman
and Claycomb). She also discusses how this worm provides a tractable genetic system in which
researchers continue to study aging, epigenetic inheritance, and the role of ncRNA in such
processes. Continuing with contributions from genetic model organisms to the field, Mekhail
then discusses how yeast, fly, mouse, and human systems have helped uncover roles of ncRNA
molecules in neural function and neurological disorders across the lifespan (Szafranski et al.).
In particular, this article discusses the role of different classes of ncRNA including miRNA and
lncRNA in healthy neural function and aging before highlighting how deleterious processes can
also be triggered by ncRNA and/or its regulators in neurodegenerative diseases especially as we
age. Suh then summarizes the rich connections between a great number of disease-linked miRNAs
and the insulin growth factor 1 (IGF-1) signaling pathway, which regulates diverse processes
from development to aging (Jung and Suh). Discussed connections between miRNAs and diseases
including cancers, diabetes, and aging are astounding. This certainly highlights the therapeutic
potential of miRNAs and miRNA-targeting nucleotides. Fish then discusses how networks of
miRNAs and lncRNAs modulate NFkB signaling, a major driver of blood vessel inflammation
(Cheng et al.). Such inflammation can start at a younger age but lead to heart attack and stroke later
in life highlighting the therapeutic potential of ncRNA modulation to treat vascular inflammation
and its associated complications across the lifespan. Mhlanga discusses how ncRNAs can be
manipulated by pathogens such as the human immunodeficiency virus (HIV) (Barichievy et al.).
This article reveals how ncRNA molecules are at the center of a power struggle between virus and
host fighting for the regulatory potential of ncRNAs. Finally, Palazzo helps us take a step back and
carefully assess the possibility that most ncRNA is junk transcriptional noise (Palazzo and Lee).
Contrary to the first impression that this article is anti-ncRNA, this hypothesis and theory article
should help the field better distinguish functional from junk ncRNA.
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In conclusion, I thank the authors and my co-guest editor for
their contributions to this research topic. I also extend my most
sincere thanks to the tireless researchers in the ncRNA field for
their dedication to decipher what continues to be one of the most
fascinating areas of biology. In addition to revealing secrets of
human health, disease, and aging, this field is helping us better
understand the evolution of processes that are so vital to our
existence as a human species. By uncovering these processes, we
learn more about who we are in an effort to extend our health
span.
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